摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-二氢-1H-环戊并[a]萘-2-羧酸 | 209224-98-6

中文名称
2,3-二氢-1H-环戊并[a]萘-2-羧酸
中文别名
——
英文名称
(+/-)-2,3-dihydro-1H-cyclopenta[α]naphthalene-2-carboxylic acid
英文别名
2,3-dihydro-1H-cyclopenta[a]naphthalene-2-carboxylic acid;4:5-Benzindan-2-carbonsaeure
2,3-二氢-1H-环戊并[a]萘-2-羧酸化学式
CAS
209224-98-6;209225-02-5;209225-03-6
化学式
C14H12O2
mdl
——
分子量
212.248
InChiKey
KLZWGWLPTNLXQK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    430.0±34.0 °C(Predicted)
  • 密度:
    1.287±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:8c9fdba330d771594683efaad59cf17a
查看

上下游信息

反应信息

  • 作为反应物:
    描述:
    2,3-二氢-1H-环戊并[a]萘-2-羧酸 以3.82 g的产率得到(-)-2,3-dihydro-1H-cyclopenta[α]naphthalene-2-carboxylic acid
    参考文献:
    名称:
    Design and Synthesis of the Potent, Orally Available, Brain-Penetrable Arylpyrazole Class of Neuropeptide Y5 Receptor Antagonists
    摘要:
    Novel arylpyrazole derivatives were synthesized and evaluated as neuropeptide Y (NPY) Y5 receptor antagonists. Compound (-)-7, which features a novel chiral 2,3dihydro- 1H-cyclopenta [a] naphthalene moiety, showed good binding affinity and antagonistic activity for the Y5 receptor. After intracerebroventricular administration in SD rats, (-)-7 significantly inhibited food intake that was induced by the centrally administered Y5-preferring agonist, bovine pancreatic polypeptide, but had only a negligible effect on NPY-induced feeding.
    DOI:
    10.1021/jm025513q
  • 作为产物:
    描述:
    1,2-双(溴甲基)-萘氢氧化钾 、 sodium hydride 作用下, 以 四氢呋喃乙醇二氯甲烷 为溶剂, 反应 18.67h, 生成 2,3-二氢-1H-环戊并[a]萘-2-羧酸
    参考文献:
    名称:
    Design and Synthesis of the Potent, Orally Available, Brain-Penetrable Arylpyrazole Class of Neuropeptide Y5 Receptor Antagonists
    摘要:
    Novel arylpyrazole derivatives were synthesized and evaluated as neuropeptide Y (NPY) Y5 receptor antagonists. Compound (-)-7, which features a novel chiral 2,3dihydro- 1H-cyclopenta [a] naphthalene moiety, showed good binding affinity and antagonistic activity for the Y5 receptor. After intracerebroventricular administration in SD rats, (-)-7 significantly inhibited food intake that was induced by the centrally administered Y5-preferring agonist, bovine pancreatic polypeptide, but had only a negligible effect on NPY-induced feeding.
    DOI:
    10.1021/jm025513q
点击查看最新优质反应信息

文献信息

  • PYRAZOLE DERIVATIVES
    申请人:BANYU PHARMACEUTICAL CO., LTD.
    公开号:EP0945438A1
    公开(公告)日:1999-09-29
    The present invention relates to a compound represented by the general formula [I]: wherein A and B rings are ortho-condensed to each other, A ring represents an aromatic carbocyclic or heterocyclic ring and B ring represents an aliphatic four- to seven-membered carbocyclic or nitrogen-containing heterocyclic ring, said nitrogen atom being possible to present at only the position where the A ring is condensed; Ar represents an aromatic carbocyclic or heterocyclic ring group which may have a substituent selected from the group consisting of a halogen atom and lower alkyl, lower alkenyl, lower haloalkyl, lower alkoxy, lower alkylthio, lower alkylamino, lower dialkylamino and aromatic carbocyclic ring groups; and R represents a substituent selected from the group consisting of a halogen atom and nitro, lower alkyl, lower alkoxy, aromatic carbocyclic ring groups and a carbonyl group having an aromatic carbocyclic ring group, or a hydrogen atom, provided that when the group represented by is the group represented by Ar is not a phenyl group nor a 4-chlorophenyl group, or its salt, a method for its preparation as well as an agent for the treatment of bulimia, obesity or diabetes comprising it as an active ingredient.
    本发明涉及通式[I]代表的化合物: 其中 A 环和 B 环彼此正交缩合,A 环代表芳香族碳环或杂环,B 环代表脂肪族四至七元碳环或含氮杂环,所述氮原子可能仅存在于 A 环缩合的位置;Ar 代表芳香碳环或杂环基团,其取代基可选自由卤素原子、低级烷基、低级烯基、低级卤代烷基、低级烷氧基、低级烷硫基、低级烷氨基、低级二烷基氨基和芳香碳环基团组成的组;和 R 代表选自卤素原子和硝基、低级烷基、低级烷氧基、芳香族碳环基团和具有芳香族碳环基团的羰基或氢原子的取代基,条件是当由 代表的基团 Ar 不是苯基,也不是 4-氯苯基、 或其盐,其制备方法以及治疗暴食症、肥胖症或糖尿病的药物,其活性成分均包含该物质。
  • US6057335A
    申请人:——
    公开号:US6057335A
    公开(公告)日:2000-05-02
  • Design and Synthesis of the Potent, Orally Available, Brain-Penetrable Arylpyrazole Class of Neuropeptide Y5 Receptor Antagonists
    作者:Nagaaki Sato、Toshiyuki Takahashi、Takunobu Shibata、Yuji Haga、Aya Sakuraba、Masaaki Hirose、Miki Sato、Katsumasa Nonoshita、Yuko Koike、Hidefumi Kitazawa、Naoko Fujino、Yasuyuki Ishii、Akane Ishihara、Akio Kanatani、Takehiro Fukami
    DOI:10.1021/jm025513q
    日期:2003.2.1
    Novel arylpyrazole derivatives were synthesized and evaluated as neuropeptide Y (NPY) Y5 receptor antagonists. Compound (-)-7, which features a novel chiral 2,3dihydro- 1H-cyclopenta [a] naphthalene moiety, showed good binding affinity and antagonistic activity for the Y5 receptor. After intracerebroventricular administration in SD rats, (-)-7 significantly inhibited food intake that was induced by the centrally administered Y5-preferring agonist, bovine pancreatic polypeptide, but had only a negligible effect on NPY-induced feeding.
查看更多